chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: HEP
Symptoms: Drug ineffective, Liver function test abnormal
Clinical narrative: Report 20010266381 describes elevated liver function tests in a 35 year old female who received hep B vaccine recombinant (Engerix-B). This report was received from the vaccinee and has not been verified by a physician or other healthcare professional. Medical history reportedly included hypertension. Concurrent conditions were not specified. The vaccinee reported that she received unspecified medication to treat hypertension. The vaccinee reported that she received a booster dose of Engerix-B on 08/22/2001. This booster dose "did not take." She then received another injection of Engerix-B on 10/05/2001. On 10/23/2001, during routine blood analysis to monitor her antihypertensive medication, it was noted that her liver function tests (NOS) were elevated. Liver function was reassessed on 10/26/2001 and 11/05/2001. The vaccinee reported that the liver function was "getting progressively worse with each measurement."
Sex: F
Vaccine: HEP
Symptoms: Pruritus, Urticaria
Clinical narrative: On an unspecified date, the vaccinee received her first 20 mcg dose of Engerix-B. Subsequently, she experienced itching and hives. As of 8 November 2001, the outcomes of the adverse events were unknown.
Age: 12.0
Sex: F
Vaccine: HEP
Symptoms: Urticaria
Clinical narrative: Report 20010267651 describes hives in an approx. 12 year old female who received hep B vaccine (Engerix-B). The vaccinee received no concurrent immunizations on 11/08/2001. Her concurrent conditions and medical history were not specified. Medical history included an unspecified "skin reaction." On 11/08/2001, the vaccinee received her first intramuscular dose of Engerix-B. "Soon" after receiving the vaccine, the vaccinee developed hives. The hives were treated with oral Benadryl. The hives lasted for approx. 12 hours and then resolved. The vaccinee was "fine" and was attending school again on 11/09/2001. Mother stated that she remembered "a skin reaction like this before" but did not remember if it occurred with a vaccine or some other type of medication. As of 11/09/2001, the adverse event had resolved.
Age: 47.0
Sex: F
Vaccine: HEP
Symptoms: Chills, Headache, Pruritus, Rash maculo-papular
Clinical narrative: Report 20010267721 describes (skin) bumps on a 47 year old female who received hep B vaccine recombinant (Engerix-B). This report was received from the vaccinee and has not been verified by a physician or other healthcare professional. Medical history, concurrent conditions, and concurrent medications were not specified. Reportedly, on 10/10/2001, the vaccinee received her first intramuscular injection of Engerix-B. Reportedly, on 10/17/2001, she developed "chicken pox-like bumps" on her forearms and scalp. Reportedly also, the vaccinee had chills and a headache which subsequently subsided. Reportedly, she then experienced new red bumps with little raised heads which were very small (1/4 inch in diameter). Some of the bumps were behind her ear. Reportedly, some of the bumps left a scab. The vaccinee stated that she has been awakened by itching. The vaccinee stated that one of her two sons experienced the same events, but his symptoms lasted for only two weeks. His bumps have healed but he has scars because he scratches. As of 11/09/2001, the vaccinee's events were ongoing.
Age: 53.0
Sex: F
Vaccine: HEP
Symptoms: Drug ineffective
Clinical narrative: Report 20010268091 describes a 53 year old female who did not respond to the hep B vaccine (Engerix-B) immunization series. Medical history, concurrent conditions, and concurrent medications were not specified. On 03/21/2001, 04/30/2001, and 09/24/2001, the vaccinee received her first, second, and third intramuscular injections of Engerix-B, respectively. A titer (NOS) drawn for this vaccinee on 11/02/2001, 39 days after the 3rd injection of Engerix-B was "negative."
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Drug ineffective
Clinical narrative: Report 20010268181 describes a 28 year old female who did not respond to the hep B vaccine (Engerix-B) immunization series. Medical history, concurrent conditions, and concurrent medications were not specified. On 11/14/2000, 12/19/2000, and 05/08/2001, the vaccinee received her first, second and third IM injections of Engerix-B, respectively. A titer (NOS) drawn for this vaccinee on 11/02/2001, approx. six months after the third injection of Engerix-B, was "negative."
Age: 29.0
Sex: F
Vaccine: HEP
Symptoms: Pruritus, Rash
Clinical narrative: Report 20000121571 describes rash in a 29 year old female who received Engerix-B for prophylaxis of hep B. The vaccinee has no allergies. Her medical history was not specified. She takes oral contraceptives (NOS). There was no known illness at the time of vaccination. She received Engerix-B at age 6 with no adverse reaction. On 03/31/2000, the vaccinee received her first 1 cc IM deltoid dose of Engerix-B. 2-3 days later, she had a small rash (red spots) with itching. She took Benadryl over the weekend (April 1-2), and in addition was treated with cortisone tablets. As of 04/03/2000, she still had itching. As of 10/27/2000, the outcome of the events is resolved.
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Autism, Drug toxicity, Nervous system disorder
Clinical narrative: An attorney alleged that a male received 3 separate doses of Acel-Imune and Hib-Titer vaccines sometime between 9/29/97 and 12/1/99. He was subsequently, dx'd with mercury poisoning and neurological injuries, including "disintegrative" (or "regressive," "late-onset," or "degenerative") autism. As of the date of this report, no further information was available.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Deafness permanent, Vertigo
Clinical narrative: A loss of hearing in right ear (complete); vertigo. Also given medication.
Age: 5.0
Sex: M
Vaccine: HEP
Symptoms: Neurodevelopmental disorder
Clinical narrative: The child received his 1st Engerix-B (lot 2036A2), 2nd (lot 2036A2) and 3rd (lot 2404A2) injections in 1995; exact dates of immunization were not provided. A dx of pervasive developmental disorder was reportedly made when the child was 5 years of age. He has reportedly been referred to an autism clinic for further testing. This report of pervasive developmental disorder is considered to be an "Other Important Medical Event".
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site mass, Injection site pain, Lymphadenopathy, Swelling
Clinical narrative: Pt rec'd bone scan w/dye 12/20/01. Rec'd flu vaccine 12/21/01. Pt states arm was painful after shot, woke at 2am 12/22/01 with pain in R arm, used a heating pad. Pain worsened over the next 2 days accompanied by swelling in R axilla and palpation of a lump. Pt went to ER 12/24/01, Temp - WNL she was told she had a swollen lymph node  related to the vaccine. Pt states swelling is slowly subsiding.
Age: 19.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Feeling cold, Skin warm, Urticaria
Clinical narrative: One hour after administration of PPD and flu shot, pt "felt dizzy". Stated his skin feels hot but he is cold. No complaints of shortness of breath. Has had no new foods or detergents. Mild urticaria noted on both forearms and hands. No "itching". No treatment given. Pt just wanted it documented.
Age: 43.0
Sex: F
Vaccine: FLUX
Symptoms: Pruritus, Urticaria
Clinical narrative: Approx. 24 hours after flu shot I became itchy and covered neck to feet in hives. Went on Benadryl.
Age: 0.2
Sex: M
Vaccine: DTAP, HBPV, PNC
Symptoms: Hypotonia, Pallor
Clinical narrative: Patient became pale and limp a few minutes after DTaP, Hibtiter, Prevnar given. Recovered spontaneously in approx one minute and was asymptomatic after that.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Shoulder pain
Clinical narrative: The pt was vaccinated on 11/16/2001. Two days later she developed left shoulder, elbow and wrist joint pain. No reaction on the injection site. Pain above persists till present 01/23/2002.
Age: 44.0
Sex: F
Vaccine: FLU3, FLU3, FLU3, FLU3
Symptoms: Hypokinesia, Injection site oedema, Injection site pain, Muscular weakness, Pain
Clinical narrative: The pt received injection on her left deltroid on 10/08/2001. Injection was immediately painful and deltoid area swelled up. Now she has decreased range of motion on her arm and she can't swing toward back or twist to hook her buckle seat belt. Arm is weak and she can't reach arm above her head. It's very painful at night and it aches all the time. Also, laying down causes more pain.
Age: 44.0
Sex: F
Vaccine: FLU3, FLU3, FLU3, FLU3
Symptoms: Bursitis, Injection site pain, Injection site swelling, Joint range of motion decreased, Neck pain
Clinical narrative: The pt received injection on her left deltroid on 10/08/2001. Injection was immediately painful and deltoid area swelled up. Now she has decreased range of motion on her arm and she can't swing toward back or twist to hook her buckle seat belt. Arm is weak and she can't reach arm above her head. It's very painful at night and it aches all the time. Also, laying down causes more pain.
Age: 44.0
Sex: F
Vaccine: FLU3, FLU3, FLU3, FLU3
Symptoms: Bursitis, Hypokinesia, Injection site reaction, Muscular weakness, Myalgia
Clinical narrative: The pt received injection on her left deltroid on 10/08/2001. Injection was immediately painful and deltoid area swelled up. Now she has decreased range of motion on her arm and she can't swing toward back or twist to hook her buckle seat belt. Arm is weak and she can't reach arm above her head. It's very painful at night and it aches all the time. Also, laying down causes more pain.
Age: 44.0
Sex: F
Vaccine: FLU3, FLU3, FLU3, FLU3
Symptoms: Tendonitis
Clinical narrative: The pt received injection on her left deltroid on 10/08/2001. Injection was immediately painful and deltoid area swelled up. Now she has decreased range of motion on her arm and she can't swing toward back or twist to hook her buckle seat belt. Arm is weak and she can't reach arm above her head. It's very painful at night and it aches all the time. Also, laying down causes more pain.
Age: 44.0
Sex: F
Vaccine: FLU3, FLU3, FLU3, FLU3
Symptoms: Injection site reaction, Injection site swelling, Joint range of motion decreased, Pain
Clinical narrative: The pt received injection on her left deltroid on 10/08/2001. Injection was immediately painful and deltoid area swelled up. Now she has decreased range of motion on her arm and she can't swing toward back or twist to hook her buckle seat belt. Arm is weak and she can't reach arm above her head. It's very painful at night and it aches all the time. Also, laying down causes more pain.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Feeling hot, Hypokinesia, Injection site swelling, Pain
Clinical narrative: Large area of swelling at injection site, warm to touch. Red, covering shoulder and extending down halfway to elbow. Seen in office 1/17/02--Benadry 1 tsp every 6 hours. Seen in office 1/19/02--still swelling, redness and complains of left leg pain not bearing weight. 1/21 swelling down, no longer limp on left leg.
Age: 48.0
Sex: F
Vaccine: HEP
Symptoms: Ear pain, Pharyngolaryngeal pain, Pyrexia, Sinus headache
Clinical narrative: Hep B3 administered 1/16/02 at 3pm. Developed fever, chills, sore throat, ear ache, sinus headache (frontal) 24 hours after vaccine given.
Age: 6.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Injection site reaction
Clinical narrative: Reaction to Dtp 12 cm length, 10.5 with
Age: 0.75
Sex: F
Vaccine: HEP, IPV
Symptoms: Pyrexia
Clinical narrative: Patient received hepatitis and oral polio at noon time. She woke up at 11:00 pm with 102 degree rectal temperature. Fever lasted 72 hours at 102 degrees during day; 103 degrees while sleeping. Fever did respond to Tylenol drops. Absolutely no other symptoms. Baby was brought to doctor on 1/11/2002. Doctor did not feel fever due to shots because there is no reaction with these shots.
Age: 1.6
Sex: F
Vaccine: DTAP, HIBV, IPV, DTP, HIBV, IPV
Symptoms: Coma, Convulsion, Urticaria
Clinical narrative: On 01/09/2002, received a call from the pt's mother stating that the child had seizure lasting 20 mins of unresponsiveness and was taken to the ER. Mom also stated that the child has been taking tempertanitrums since birth with periods of unresponsiveness. Physician told mom that the episode was not feel that it was vaccine related. Patient had a seizure 15-20 minutes unresponsive.  ER then days after she had severe hives.
Age: 1.6
Sex: F
Vaccine: DTAP, HIBV, IPV, DTP, HIBV, IPV
Symptoms: Loss of consciousness, Staring, Urticaria
Clinical narrative: On 01/09/2002, received a call from the pt's mother stating that the child had seizure lasting 20 mins of unresponsiveness and was taken to the ER. Mom also stated that the child has been taking tempertanitrums since birth with periods of unresponsiveness. Physician told mom that the episode was not feel that it was vaccine related. Patient had a seizure 15-20 minutes unresponsive.  ER then days after she had severe hives.
Age: 21.0
Sex: M
Vaccine: HEP, HEPA
Symptoms: Asthenia, Convulsion, Hepatitis C virus, Nausea
Clinical narrative: Pt received both vaccines and then left nauseated and weak. Was lowereed to the floor with feet elevated. Began with seizure and less than 1 minute. Phoned 911, monitored vitals.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Erythema, Pyrexia, Rash, Rash papular
Clinical narrative: Fever with rash starting on 1/17/2002. Fever lasted 48 hours after 24 hours of fever, erythema, papule type rash developed. Seen in office 1/21/02 and continued rash but no fever.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Agitation, Histrionic personality disorder, Hyperacusis, Irritability
Clinical narrative: Parents feel patient had a change in personality after her first set of immunizations. She seemed to develop hyperacoutis and became very fussy, spending a lot of time crying.  Hyperacoutis improved about 2 weeks ago.
Sex: M
Vaccine: LYME
Symptoms: Hypoaesthesia
Clinical narrative: Report 2002000877-1 describes numbness in an adult male who received Lyme disease vaccine recombinant Ospa (LYMERIX). medical history, concurrent conditions, and concurrent medications were not specified. On an unspecified date, the vaccinee received an injection of LYMErix in his arm. he subsequently experienced numbness of the arm; the numbness spread to his chest. The nurse stated that she "probably hit his nerve to cause this reaction." Outcome of the event was not provided. The adverse event "numbness" dose not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the June 28, 2000 letter. Comment: The nurse reported that she administered LYMErix lot LY1Y7F9; however, this is not a valid lot number. A follow up report received 7/26/2002 adds: There was no relevant medical history...On 11/30/2001, an unspecified time post-immunization, he experienced "mild" numbness of the arm. The numbness spread to his chest and down the arm to the fingers. The numbness resolved after "several hours", without treatment. (The nurse) also indicated that the event was possibly related to Lymerix.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Apnoea, Laboratory test abnormal, Pulse absent, Sudden infant death syndrome
Clinical narrative: On 12/4/00, the infant received his 2nd injection of Engerix-B. That day, he also received his 1st injections of Infanrix, Prevnar, Act-Hib and IPOL. Three days, post vax, on 12/7/00, he was taken to the ER. Upon arrival, he was pulseless and had no respiratory effort. An unspecified "PH" was 6.29. He did not respond to resuscitative efforts and died. The coroner unofficially reported the cause of death as sudden infant death syndrome.
Age: 43.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Blood creatine phosphokinase increased, Blood urea increased, Glomerulonephritis, Immunoglobulins increased, Nasal congestion
Clinical narrative: It was reported that a 43 year old female pt received a Fluzone SV '00-'01 vaccination on 12/5/00. The pt developed flu-like symptoms (aches, congested and continuous fever). On 12/7/00, the pt was seen in the physician's office. The physician prescribed antibiotics for a week and the symptoms never resolved. The pt began to vomit frequently. On 12/19/00, she was admitted to the hospital. The pt was hospitalized for 3 weeks and is now on dialysis, 3 X a week. The pt is the reporter and did not believe that her physician ever reported this event.
Age: 43.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pain, Pyrexia, Renal failure, Vomiting
Clinical narrative: It was reported that a 43 year old female pt received a Fluzone SV '00-'01 vaccination on 12/5/00. The pt developed flu-like symptoms (aches, congested and continuous fever). On 12/7/00, the pt was seen in the physician's office. The physician prescribed antibiotics for a week and the symptoms never resolved. The pt began to vomit frequently. On 12/19/00, she was admitted to the hospital. The pt was hospitalized for 3 weeks and is now on dialysis, 3 X a week. The pt is the reporter and did not believe that her physician ever reported this event.
Age: 43.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Anaemia, Apnoea, Asthenia, Faeces discoloured, Glomerulonephritis
Clinical narrative: It was reported that a 43 year old female pt received a Fluzone SV '00-'01 vaccination on 12/5/00. The pt developed flu-like symptoms (aches, congested and continuous fever). On 12/7/00, the pt was seen in the physician's office. The physician prescribed antibiotics for a week and the symptoms never resolved. The pt began to vomit frequently. On 12/19/00, she was admitted to the hospital. The pt was hospitalized for 3 weeks and is now on dialysis, 3 X a week. The pt is the reporter and did not believe that her physician ever reported this event.
Age: 43.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Goodpasture's syndrome, Pharyngitis, Pulmonary oedema, Pyrexia, Rash
Clinical narrative: It was reported that a 43 year old female pt received a Fluzone SV '00-'01 vaccination on 12/5/00. The pt developed flu-like symptoms (aches, congested and continuous fever). On 12/7/00, the pt was seen in the physician's office. The physician prescribed antibiotics for a week and the symptoms never resolved. The pt began to vomit frequently. On 12/19/00, she was admitted to the hospital. The pt was hospitalized for 3 weeks and is now on dialysis, 3 X a week. The pt is the reporter and did not believe that her physician ever reported this event.
Age: 43.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Renal failure, Renal failure acute, Sinus congestion, Vomiting
Clinical narrative: It was reported that a 43 year old female pt received a Fluzone SV '00-'01 vaccination on 12/5/00. The pt developed flu-like symptoms (aches, congested and continuous fever). On 12/7/00, the pt was seen in the physician's office. The physician prescribed antibiotics for a week and the symptoms never resolved. The pt began to vomit frequently. On 12/19/00, she was admitted to the hospital. The pt was hospitalized for 3 weeks and is now on dialysis, 3 X a week. The pt is the reporter and did not believe that her physician ever reported this event.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Hypernatraemia, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Eye disorder, Hypernatraemia, Hypoglycaemia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Laboratory test abnormal, Pyrexia, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hypoglycaemia, Laboratory test abnormal
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Pyrexia, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hyperventilation, Hypoglycaemia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hyponatraemia, Ketosis, Laboratory test abnormal, Pyrexia, Tachycardia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Blood urea increased, Convulsion, Diarrhoea, Hyperchloraemia, Hypernatraemia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hypoglycaemia, Platelet count increased, Pyrexia, Strabismus, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.35
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received an IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/28/01. The next day, the pt experienced a seizure and a fever of 104F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From additional correspondence received on 1/14/02, the correct vaccination and adverse events onset dates were provided. The pt experienced seizures, diarrhea, hypoglycemia and hypernatremia. The pt was transferred to a hospital in another state. The pt was hospitalized for 4 days. Reportedly, the pt recovered from this experience.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Hypernatraemia, Pyrexia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Eye disorder, Hypernatraemia, Hypoglycaemia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Laboratory test abnormal, Pyrexia, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hypoglycaemia, Laboratory test abnormal
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Pyrexia, White blood cell count increased
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hyperventilation, Hypoglycaemia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hyponatraemia, Ketosis, Laboratory test abnormal, Pyrexia, Tachycardia
Clinical narrative: It was reported that a 4 month old female pt received IPOL, an Infanrix, a Prevnar and a Comvax vaccination on 11/29/01. The next day, the pt experienced a seizure and a fever of 105F. The pt was taken to the local ER. Treatment of the events was not specified. The pt was improving as of 11/30/01. Further information is requested. From follow-up correspondence received on 1/14/02, it was reported that the pt developed a fever of 105F, her eyes rolled back and her shoulders and chest jerked, on and off for 20 minutes. Reportedly, the pt recovered from this experience. The correct vaccination and adverse event onset dates were provided. The vaccine lot numbers and additional pt information were also provided. This case is closed. From faxed correspondence received at manufacturer on 5/13/02 it was reported: It was also noted that the pt was possibly treated with lorazepam, phenytoin and ceftriaxone. However, the healthcare professional could not verify this treatment in the outpatient office chart because it might have been used in the ER. The healthcare professional reported that the physician thinks that the adverse reactions are associated with the pertussis in the diphtheria toxoid/pertussis vaccine/teta (Infanrix) vaccination. Therefore, the pt will not receive anymore of the pertussis. The pt's seizure and fever of 105 deg F were considered to be other important medical events (OMIC). This report was assigned VAERS ID number 179712 or 180563. From faxed follow up info received at manufacturer on 6/17/02 it was reported that the pt had the following lab results: blood cultures negative, urinalysis negative, blood bicarbonate 17 mcg/L, blood urea 22mg/dL, hematocrit 36.59%, platelets 413,600, WBC 30,000 and 21,500, segmented neutrophil count 16% (also reported as 50% segs, 154 bands, 134 lymlphocytes) and lymphocytes 134.